Literature DB >> 15621130

Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.

A S Mathis1, N K Shah, G S Friedman.   

Abstract

Voriconazole is currently contraindicated for use with sirolimus. We report our experience with voriconazole/sirolimus in two renal transplant recipients. To our knowledge, this is the first experience with voriconazole/sirolimus. An interaction requiring a 75% to 87.5% sirolimus dose reduction was noted, but goal trough levels and clinical tolerability were achieved.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15621130     DOI： 10.1016/j.transproceed.2004.09.043

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


  4 in total

1.  Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT.

Authors:  I Ceberio; K Dai; S M Devlin; J N Barker; H Castro-Malaspina; J D Goldberg; S Giralt; N G Adel; M-A Perales
Journal:  Bone Marrow Transplant       Date:  2015-01-19       Impact factor: 5.483

2.  Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient.

Authors:  E M Billaud; C Antoine; M Berge; I Abboud; S Lefeuvre; M Benammar; D Glotz
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 3.  The enzymatic basis of drug-drug interactions with systemic triazole antifungals.

Authors:  Yasmine Nivoix; Dominique Levêque; Raoul Herbrecht; Jean-Claude Koffel; Laurence Beretz; Genevieve Ubeaud-Sequier
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Urinary tract aspergillosis in a patient with chronic kidney disease.

Authors:  Linghong Zhou; Huazhen Zhao; Zhongqing Chen; Liping Zhu
Journal:  BMJ Case Rep       Date:  2017-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.